Technical Analysis for IMAB - I-Mab
Grade | Last Price | % Change | Price Change |
---|---|---|---|
F | 1.81 | -2.69% | -0.05 |
IMAB closed down 2.69 percent on Monday, March 18, 2024, on 71 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.
Earnings due: Mar 28
*** please verify all earnings dates ***ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Flat | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Fell Below 50 DMA | Bearish | 0.00% | |
20 DMA Support | Bullish | 0.00% | |
Inside Day | Range Contraction | 0.00% | |
Gapped Down | Weakness | 0.00% | |
20 DMA Support | Bullish | -2.69% | |
Crossed Above 50 DMA | Bullish | -2.69% | |
Expansion Pivot Buy Setup | Bullish Swing Setup | -2.69% | |
Outside Day | Range Expansion | -2.69% | |
Gapped Down | Weakness | -2.69% | |
NR7 | Range Contraction | 0.56% |
Alert | Time |
---|---|
Possible Inside Day | about 14 hours ago |
50 DMA Resistance | about 17 hours ago |
50 DMA Support | about 18 hours ago |
2x Volume Pace | about 18 hours ago |
1.5x Volume Pace | about 18 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 03/28/2024
I-Mab is a clinical stage biopharmaceutical company. It engages in discovering, developing and commercialization of differentiated biologics to treat diseases with significant unmet medical needs, particularly cancers and autoimmune disorders. The company was founded by Jingwu Zhang Zang on June 30, 2016 and is headquartered in Pudong, China.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Disease Pharmacy Medication Autoimmune Disorders Immune Disorders
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Disease Pharmacy Medication Autoimmune Disorders Immune Disorders
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 3.88 |
52 Week Low | 1.16 |
Average Volume | 482,443 |
200-Day Moving Average | 1.98 |
50-Day Moving Average | 1.82 |
20-Day Moving Average | 1.76 |
10-Day Moving Average | 1.79 |
Average True Range | 0.13 |
RSI (14) | 51.69 |
ADX | 11.72 |
+DI | 22.48 |
-DI | 20.48 |
Chandelier Exit (Long, 3 ATRs) | 1.54 |
Chandelier Exit (Short, 3 ATRs) | 1.91 |
Upper Bollinger Bands | 1.93 |
Lower Bollinger Band | 1.58 |
Percent B (%b) | 0.66 |
BandWidth | 19.98 |
MACD Line | 0.02 |
MACD Signal Line | 0.00 |
MACD Histogram | 0.0114 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 1.99 | ||||
Resistance 3 (R3) | 1.98 | 1.92 | 1.96 | ||
Resistance 2 (R2) | 1.92 | 1.87 | 1.92 | 1.95 | |
Resistance 1 (R1) | 1.86 | 1.84 | 1.89 | 1.87 | 1.94 |
Pivot Point | 1.80 | 1.80 | 1.81 | 1.80 | 1.80 |
Support 1 (S1) | 1.74 | 1.75 | 1.77 | 1.75 | 1.68 |
Support 2 (S2) | 1.68 | 1.72 | 1.68 | 1.67 | |
Support 3 (S3) | 1.62 | 1.68 | 1.66 | ||
Support 4 (S4) | 1.63 |